Actavis (ACT) says it's filed an Abbreviated New Drug Application with the FDA seeking approval...

|By:, SA News Editor

Actavis (ACT) says it's filed an Abbreviated New Drug Application with the FDA seeking approval to market Drospirenone/Ethinyl Estradiol/Levomefolate Calcium Tablets And Levomefolate Calcium Tablets, a generic version of Bayer's (BAYRY.PK) Safyral, which is approved to prevent pregnancy in women who elect to use an oral contraceptive, and to provide folate supplementation. Merck (MRK), Bayer and Bayer Healthcare Pharmaceuticals filed suit against ACT yesterday in the U.S. District Court seeking to prevent ACT from filing.